RAC Past Papers

About This Presentation
Title:

RAC Past Papers

Description:

Now you can pass the latest exams questions of any exam. Exams4sure.net provides you best study material. We provide you latest exam questions of RAC exam. We ensure you that you will pass your exam in first attempt. We provide you latest news of your certification. Before you can take your exam you should try our demo it help you to understand the certification syllabus. For more info visit here – PowerPoint PPT presentation

Number of Views:11

less

Transcript and Presenter's Notes

Title: RAC Past Papers


1
Pass Regulatory Affairs Certification (RAC)
Global Scope exam in just 24 HOURS! 100 REAL
EXAM QUESTIONS ANSWERS Regulatory Affairs
Certification (RAC) Global Scope Buy Complete
Questions Answers File from http//www.exams4sure.
net/raps/rac-gs-exam-questions-dumps.html 100
Exam Passing Guarantee Money Back Assurance
2
  • Sample Questions
  • Question 1
  • Which of the following statements regarding the
    off-label use of drugs is CORRECT?
  • Although the regulatory authority reviews and
    approves drugs for specific indications, the
    approval does not limit the use of those drugs in
    clinical practice.
  • The regulatory authority does not restrict
    physician prescribing for off-label
  • indications or regulate the manufacturer's
    promotion for such use.
  • Sponsors are allowed to distribute publications
    about unapproved uses of approved drugs and
    devices as long as the marketing application is
    under review by the regulatory authority.
  • The peer-reviewed literature can ensure
    high-quality off-label promotion of medications,
    thereby increasing access to much needed drugs
    and devices.
  • Answer A
  • Question 2
  • A drug product presents degradation during the
    manufacturing process. In addition to the
    amount, what information should be provided FIRST
    in order to use API overage?
  • Specification
  • Formulation
  • Property
  • Justification
  • Answer D
  • Question 3

3
  • requirement and received approval. Which action
    should the regulatory affairs professional take
    FIRST?
  • Discuss with the regulatory apriority and attempt
    to reach an acceptable solution.
  • Inform the internal departments to redesign the
    product to comply with this requirement.
  • Inform the regulatory authority that such a
    requirement is not applicable to the product.
  • Notify senior management that the product cannot
    be registered.
  • Answer A
  • Question 4
  • Which of the following statements regarding
    export regulations for an approved product is
    CORRECT?
  • The product must not be in accord with the
    specifications of the foreign purchaser.
  • The product must not be in conflict with the laws
    of the country to which it is intended for
    export.
  • The product must not be labeled on the outside of
    the shipping package that it is intended for
    export.
  • The product must not be sold or offered for sale
    in domestic commerce.
  • Answer B
  • Question 5
  • The intermediate manufacturing process was
    changed during development of a pharmaceutical.
    The change may impact the API specification.
    Which functional area is responsible for the
    final approval of the change?
  • Production
  • Analytical

4
  • Question 6
  • Under which of the following circumstances would
    a regulatory authority require a more detailed
    premarket submission, a more rigorous audit,
    and/or the provision of more performance
    evaluation data than would normally apply to an
    IVD device of that risk class?
  • The device is an updated version of a compliant
    device from the same manufacturer and contains
    no substantive change.
  • Internationally recognized standards are
    available to cover the main aspects of the
    device and have been used by the manufacturer.
  • The manufacturer's experience level with the type
    of IVD medical device is limited.
  • The device incorporates well-established
    technology that is already present in the
    market.
  • Answer C
  • Question 7
  • According to WHO, what are the temperature and
    humidity conditions for a Zone IVb long term
    stability study?
  • 25 C and 60 RH
  • 30 C and 35 RH
  • 30c C and 65 RH
  • 30 C and 75 RH
  • Answer D
  • Question 8

5
  • any regulatory action." Which action would be the
    most appropriate FIRST step for the company to
    take?
  • Contact the regulatory authority to argue that
    its conclusions are wrong.
  • Contact the regulatory authority to discuss its
    findings.
  • Repeat the Hepatotoxicity tests and send the
    results to the regulatory authority.
  • Wait for the regulatory authority's final
    publication on its findings.
  • Answer B
  • Buy Complete Questions Answers File from
  • http//www.exams4sure.net/raps/rac-gs-exam-questio
    ns-dumps.html
  • 100 Exam Passing Guarantee Money Back
    Assurance
  • PDF Version Test Engine Software Version
  • 90 Days Free Updates Service
  • Valid For All Countries

6
http//www.exams4sure.net/raps/rac-gs-exam-questio
ns-dumps.html
Write a Comment
User Comments (0)